Yoon Ji Choi

2.2k total citations
111 papers, 1.1k citations indexed

About

Yoon Ji Choi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yoon Ji Choi has authored 111 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 37 papers in Pulmonary and Respiratory Medicine and 27 papers in Surgery. Recurrent topics in Yoon Ji Choi's work include Lung Cancer Treatments and Mutations (19 papers), Colorectal Cancer Treatments and Studies (12 papers) and Cancer Genomics and Diagnostics (10 papers). Yoon Ji Choi is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), Colorectal Cancer Treatments and Studies (12 papers) and Cancer Genomics and Diagnostics (10 papers). Yoon Ji Choi collaborates with scholars based in South Korea, Japan and United States. Yoon Ji Choi's co-authors include Kyong Hwa Park, Yeul Hong Kim, Eun Joo Kang, Sang Won Shin, Jung Sun Kim, Seunghun Hong, Seung Tae Kim, Jun Suk Kim, Jae Hong Seo and Sung Yong Lee and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Yoon Ji Choi

102 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoon Ji Choi South Korea 18 456 282 251 170 155 111 1.1k
Iris Burkholder Germany 19 363 0.8× 356 1.3× 343 1.4× 245 1.4× 191 1.2× 62 1.4k
Li Ma China 22 297 0.7× 517 1.8× 250 1.0× 198 1.2× 192 1.2× 99 1.3k
Samuel S. Dychter United States 14 544 1.2× 268 1.0× 256 1.0× 127 0.7× 114 0.7× 25 1.2k
George Kyrgias Greece 17 301 0.7× 228 0.8× 175 0.7× 114 0.7× 157 1.0× 75 883
Liam Grogan Ireland 18 424 0.9× 164 0.6× 281 1.1× 118 0.7× 128 0.8× 66 978
Alexis Vallard France 18 357 0.8× 364 1.3× 324 1.3× 140 0.8× 208 1.3× 110 1.2k
Klaus Orth Germany 21 275 0.6× 450 1.6× 193 0.8× 316 1.9× 234 1.5× 72 1.2k
Hui Xie China 21 379 0.8× 318 1.1× 332 1.3× 188 1.1× 210 1.4× 95 1.5k
Mi‐Sook Kim South Korea 21 284 0.6× 383 1.4× 182 0.7× 363 2.1× 110 0.7× 71 1.3k
Elisabetta Petracci Italy 17 480 1.1× 365 1.3× 282 1.1× 144 0.8× 274 1.8× 62 1.1k

Countries citing papers authored by Yoon Ji Choi

Since Specialization
Citations

This map shows the geographic impact of Yoon Ji Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoon Ji Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoon Ji Choi more than expected).

Fields of papers citing papers by Yoon Ji Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoon Ji Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoon Ji Choi. The network helps show where Yoon Ji Choi may publish in the future.

Co-authorship network of co-authors of Yoon Ji Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoon Ji Choi. A scholar is included among the top collaborators of Yoon Ji Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoon Ji Choi. Yoon Ji Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Guangxian, Sang‐Eun Lee, Yoon Ji Choi, et al.. (2025). Bridge-type aptamer-Au@Pt-MXene-based sensing platform for detection of multiple organophosphorus pesticides. Microchemical Journal. 211. 113084–113084.
2.
Choi, Yoon Ji, et al.. (2025). Therapeutic Potential of Stem Cell-Derived Exosomes in Skin Wound Healing. Biomimetics. 10(8). 546–546. 1 indexed citations
3.
4.
Shin, Junghyun, et al.. (2024). Automated System for Attomolar-Level Detection of MiRNA as a Biomarker for Influenza A Virus. ACS Applied Materials & Interfaces. 16(26). 33897–33906. 1 indexed citations
5.
Kim, Yu Jung, Yu Jung Kim, Koung Jin Suh, et al.. (2024). Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second‐line treatment (EAGLES, Korean Cancer Study Group UN18‐06). Cancer. 131(1). e35609–e35609. 2 indexed citations
6.
Kang, Eun Joo, Yaewon Yang, Sang-Ho Lee, et al.. (2024). A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17). ESMO Open. 9(9). 103668–103668. 2 indexed citations
7.
Choi, Yoon Ji, Sang‐Eun Lee, Sang‐Eun Lee, et al.. (2024). MXene/Hydrogel-based bioelectronic nose for the direct evaluation of food spoilage in both liquid and gas-phase environments. Biosensors and Bioelectronics. 256. 116260–116260. 15 indexed citations
9.
Kim, Ju Won, Soo Hyun Lee, Hye Sook Kim, et al.. (2021). Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13). Cytokine. 142. 155487–155487. 8 indexed citations
10.
Choi, Sun-Ho, Minhyeok Lee, Young Soo Park, et al.. (2020). Clinical Implication of Concordant or Discordant Genomic Profiling between Primary and Matched Metastatic Tissues in Patients with Colorectal Cancer. Cancer Research and Treatment. 52(3). 764–778. 6 indexed citations
11.
Lee, Soo Hyun, Min Ja Kim, Yoon Ji Choi, et al.. (2020). Innovative countermeasures can maintain cancer care continuity during the coronavirus disease-2019 pandemic in Korea. European Journal of Cancer. 136. 69–75. 10 indexed citations
13.
14.
Kim, Ju Won, Yoon Ji Choi, Youn Seon Choi, et al.. (2019). Completion rate of physician orders for life-sustaining treatment for patients with metastatic or recurrent cancer: a preliminary, cross-sectional study. BMC Palliative Care. 18(1). 84–84. 14 indexed citations
15.
Kim, Jung Sun, et al.. (2017). A Case Report of Primary Pericardial Malignant Mesothelioma Treated with Pemetrexed and Cisplatin. Journal of Korean Medical Science. 32(11). 1879–1879. 4 indexed citations
16.
Kim, Se Hyun, Kyung Hae Jung, Tae‐Yong Kim, et al.. (2016). Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study. Cancer Research and Treatment. 48(4). 1373–1381. 8 indexed citations
17.
Park, Kyong Hwa, Yoon Ji Choi, Kyung-Han Ro, et al.. (2016). Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis. Japanese Journal of Clinical Oncology. 46(9). 845–849. 13 indexed citations
18.
Park, Yeon Hee, Tae Yong Kim, Young‐Hyuck Im, et al.. (2016). Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results. Cancer Research and Treatment. 49(2). 423–429. 9 indexed citations
19.
Lee, Je‐Hwan, Je‐Hwan Lee, Sung‐Han Kim, et al.. (2009). Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD. Bone Marrow Transplantation. 45(7). 1174–1180. 17 indexed citations
20.
Kim, J G, Y.S. Chae, D H Kim, et al.. (2006). Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer. British Journal of Cancer. 94(10). 1407–1411. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026